Skip to content
★ Sign in to follow
נש

נקסטפרם-ש Stock: price and insider trades · Israel

נקסטפרם-ש: what insiders have been doing

נקסטפרם-ש is a listed company. Filings by its managers are published through TASE (ISA). Between 8 November 2025 and 8 November 2026, 7 insiders published 15 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

No insider has bought נקסטפרם-ש shares on the open market in the past twelve months.

Across the 530 companies tracked on its exchange, the median is 13 filings; at 15 filings, this issuer sits above that mark.

Source: insider filings from TASE (ISA). Past trades are no guide to future returns.

Insider Decl.
15
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

Last declaration on 29 September 2026
Declarations15 total
  • ●
    Chairman of the BoardExecutives
    7TASE
    124,742 shares3.1% of flowShareXTAETASE:1841:7686:1171933:2026-09-24
  • ●
    Chairman of the BoardExecutives
    7TASE
    141,242 shares3.2% of flowShareXTAETASE:1841:7686:1171933:2026-09-17
  • ●
    Substantial ShareholderExecutives
    13TASE
    20,000 shares100.0% of flowShareXTAETASE:1841:13315:1171933:2026-09-17
  • ●
    Chairman of the BoardExecutives
    7TASE
    176,400 shares3.8% of flowShareXTAETASE:1841:7686:1171933:2026-09-16
  • ●
    Chairman of the BoardExecutives
    8TASE
    186,400 shares13.3% of flowShareXTAETASE:1841:7686:1171933:2026-09-14
  • ●
    Chairman of the BoardExecutives
    8TASE
    193,900 shares13.9% of flowShareXTAETASE:1841:7686:1171933:2026-09-09
  • ●
    Chairman of the BoardExecutives
    8TASE
    205,700 shares14.8% of flowShareXTAETASE:1841:7686:1171933:2026-09-07
  • ●
    Chairman of the BoardExecutives
    9TASE
    215,700 shares15.7% of flowShareXTAETASE:1841:7686:1171933:2026-08-26
  • ●
    Substantial ShareholderExecutives
    13TASE
    20,000 shares100.0% of flowShareXTAETASE:1841:14354:1171933:2026-08-26
  • ●
    Chairman of the BoardExecutives
    9TASE
    235,700 shares16.9% of flowShareXTAETASE:1841:7686:1171933:2026-08-24
  • ●
    Chairman of the BoardExecutives
    9TASE
    252,500 shares18.4% of flowShareXTAETASE:1841:7686:1171933:2026-08-17
  • ●
    Executives
    10TASE
    252,500 shares100.0% of flowShareXTAETASE:1841:13875:1171933:2025-12-01
  • ●
    Executives
    0TASE
    13,000 shares100.0% of flowShareXTAETASE:1841:10598:1171933:2025-05-08
  • ●
    Executives
    0TASE
    19,392 shares100.0% of flowShareXTAETASE:1841:12233:1171933:2025-05-08
  • ●
    Executives
    0TASE
    5,966 shares100.0% of flowShareXTAETASE:1841:12237:1171933:2025-05-08

15 of 15 declarations

About נקסטפרם-ש

NextPharm-S is a company listed on the XTAE market, specializing in the pharmaceutical sector.